project id: TCGA-UCEC; case submitter id: TCGA-EO-A3AZ; source center: 23; state: released; a260 a280 ratio: 1.79; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.5; rna integrity number: 7.2; age at index: 80; days to birth: -29234; ethnicity: not reported; gender: female; race: not reported; vital status: Alive; year of birth: 1931; age at diagnosis: 29234; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 826.0; figo stage: Stage IB; icd 10 code: C54.1; last known disease status: not reported; morphology: 8441/3; primary diagnosis: Serous cystadenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Endometrium; synchronous malignancy: No; tissue or organ of origin: Endometrium; tumor grade: Not Reported; year of diagnosis: 2011; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to sample procurement: 0; initial weight: 120.0; portion submitter id: TCGA-EO-A3AZ-01A-12; percent lymphocyte infiltration: 70.0; percent monocyte infiltration: 10.0; percent necrosis: 5.0; percent neutrophil infiltration: 10.0; percent normal cells: 0.0; percent stromal cells: 15.0; percent tumor cells: 80.0; percent tumor nuclei: 80.0;